Developing better model systems for drug and toxicity testing. Learn more.
-
Research
-
- Funding & Notices
-
- News & Media
- About Translation
-
- About NCATS
-
NCATS Programs & Initiatives
- 3-D Tissue Bioprinting Program
- Stem Cell Translation Laboratory
- Assay Development and Screening Technology (ADST)
- Biomedical Data Translator
- Bridging Interventional Development Gaps (BrIDGs)
- Chemistry Technology
- Discovering New Therapeutic Uses for Existing Molecules
- Genetic and Rare Diseases Information Center (GARD)
- Matrix Combination Screening
- Early Translation Branch (ETB)
- A Specialized Platform for Innovative Research Exploration (ASPIRE)
- A Translational Approach to Addressing COVID-19
- Antiviral Program for Pandemics
- Clinical Trial Readiness for Rare Diseases, Disorders and Syndromes
- Multidisciplinary Machine-Assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey
- National COVID Cohort Collaborative (N3C)
- The Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium (BGTC)
- NIH Common Fund Programs
- Rare Diseases Registry Program (RaDaR)
- Tissue Chip for Drug Screening
- Toxicology in the 21st Century (Tox21)
- Functional Genomics Lab
- Therapeutics for Rare and Neglected Diseases (TRND)
- About NCATS
- Home
- Research
- Preclinical Innovation
- Testing & Predictive Models
Testing & Predictive Models
NCATS Assay on Top 10 Scientific Achievements List
A scientific society honored NCATS scientists for creating a screening test to identify molecules that block the growth of new blood vessels. The test could be useful in cancer research.
Efficacy & ToxicologyProviding the research community with robust, reliable tools for testing chemical safety and efficacy.
Molecular TargetsDeveloping new methods to validate potential drug targets efficiently and predictably.
Core TechnologiesUsing state-of-the-art resources to enable the ongoing operation of all NCATS translational research activities.
Providing the research community with robust, reliable tools for testing chemical safety and efficacy.
Developing new methods to validate potential drug targets efficiently and predictably.
Using state-of-the-art resources to enable the ongoing operation of all NCATS translational research activities.
Work with Us
NCATS preclinical programs and resources focus on key obstacles and inefficiencies in the translational process, overcoming bottlenecks that slow the development of new treatments for patients.
Learn more about how to access NCATS programs and expertise.
Learn more about NCATS’ Achievements in Advancing Translational Sciences.
Drug and Toxicity Testing at NCATS
Predicting the biological effects of drugs, chemicals and interventions is fraught with hazard. Many candidate drugs fail in human clinical trials because they are found to be unsafe or ineffective, despite promising preclinical studies in animal and cell models.
NCATS is developing model systems for drug and toxicity testing that more closely resemble human physiology and more accurately reflect how our bodies will react to an experimental compound. Such advances could save enormous amounts of time and expense by preventing people in clinical studies from being exposed to potentially harmful or ineffective candidate drugs. Scientists also can use these models to study the basic biology of disease, predict toxicity or other physiological processes, and evaluate environmental chemicals. The model systems support NIH’s position that non-animal model approaches can reduce the need for animals in research but will require further improvement to completely replace them.
- News & Media
- Funding & Notices
-